How these papers were chosen among the week's 393 papers

All 393 papers of the week whose main category is in this field were read, title and start of the abstract, and 23 were kept. They were then ordered by what can be counted: how many research profiles of our readers they come close to, whether a rising topic of the field includes them, and how many categories they were posted in. The abstracts of the first 24 were read in full to choose these, no more than two from one category and one per team.

The 5 numbers of the text were checked against the abstracts. 23 statements on what the papers found were looked for word for word in their abstracts.

Sources: bioRxiv, medRxiv.

A changing hippocampus can still remember #

A memory need not depend on an entirely stable neural map. After two days exploring a branching maze, mice retained navigational advantages through repeated 90-day absences over as much as a year. On returning, they explored more efficiently and resumed direct journeys to a reward sooner. Chronic calcium imaging followed the same hippocampal neurons across visits: most changed their preferred locations, yet activity across the population still carried a recognizable trace of the earlier map.

Some features were especially durable. Neurons that shifted their preferred locations tended to retain a preference for the same branching level, preserving an aspect of the maze’s geometry. Better preservation of this tuning accompanied more efficient exploration, while more reliable activity near the reward accompanied earlier direct runs there. The preprint suggests that lasting memory can coexist with substantial cellular change, although these associations do not establish which surviving traces are necessary for remembering.

A molecular warning before prion symptoms #

For people carrying an inherited prion-disease mutation, a test of cerebrospinal fluid may help distinguish genetic risk from an approaching clinical transition. Researchers analysed longitudinal samples from 94 PRNP E200K mutation carriers using RT-QuIC, an assay that detects the ability of abnormal prion protein to seed amyloid formation. Eleven carriers developed disease, and all had tested positive before symptoms. First positivity appeared a median of 2.0 years before onset.

Carriers who remained asymptomatic stayed negative throughout follow-up, while a positive result marked substantially higher short-term conversion risk. This clinical preprint offers a potential way to select and monitor participants in preventive studies: intervening before symptoms requires knowing when disease biology is becoming active. It does not yet establish a universal countdown to onset; the reported interval varied, and the evidence concerns this mutation.

When a consciousness test finds commands that were never given #

An EEG signal interpreted as following a command can have profound consequences for an unresponsive patient. But how often would the analysis declare success without any command being issued? Researchers reimplemented published analyses and tested them on command-free recordings, including clinical EEG patients, people with prolonged disorders of consciousness and comatose patients after cardiac arrest. Some procedures produced positive calls far above a 5% benchmark, with rates reaching 27.3% after cardiac arrest.

The problems were not interchangeable: they included mishandling dependence within commands, selecting among analytical configurations and times, and using a permissive threshold. A correction to one analysis, fixed before testing on new patients, sharply reduced false calls while retaining strong detection for imagery-versus-rest sessions. The broader lesson of this preprint is that detecting genuine responses is not enough: a diagnostic claim also needs a measured false-call rate for the complete decision procedure. Even imagery-versus-rest detection may indicate task engagement rather than the requested imagery itself.

Sleep’s genetic link to the brain’s insulation #

A gene associated with sleep may act through the cells that support and insulate neurons, rather than through neurons alone. Across mice, zebrafish and fruit flies, researchers found that DPYD or its counterparts promoted sleep through glial lipid biology. In mice and zebrafish, losing the gene reduced myelination and sleep, independently of its established role in pyrimidine breakdown. Genetic and drug manipulations in zebrafish also showed that changing myelination was sufficient to alter sleep duration.

Fruit flies lack myelin, but their version of the gene acted in ensheathing glia through lipid-droplet formation. The study also connected a human sleep-associated genetic variant to a regulatory element that contacts the DPYD promoter specifically in oligodendrocytes. Together, these experiments offer a route from a human genetic association to a cellular mechanism. The human connection remains a regulatory link, however, rather than a demonstration that manipulating DPYD changes human sleep.

A human-specific gene responds to experience #

Human cortical development leaves an unusually long window for experience to shape connections. A preprint identifies FRMPD2B, a human-specific gene, as a possible contributor to that flexibility. The gene is expressed mainly in neurons that connect cortical regions, during postnatal development and childhood. Experiments found that it promoted dendrite, axon and synapse development and was required for proper morphology in human cortical neurons transplanted into another species.

Its expression also responded in both directions to neuronal activity and experience. The researchers traced this responsiveness to promoter remodelling by a retrotransposon insertion after the gene arose through partial duplication. That supplies a concrete example of how evolutionary changes can modify not just what a gene does, but when experience recruits it. The work connects gene regulation to circuit development; it does not directly demonstrate an effect on human cognitive abilities.

Pain helps the brain register inflammation #

Pain may be more than a consequence of inflammation: nociceptive input may help the brain encode the inflammatory event itself. Human fMRI and mouse activity mapping revealed a distinct brain state associated with peripheral inflammation. In mice, removing TRPV1+ sensory neurons or administering analgesia disrupted that organization and prevented the insular cortex from forming retrievable representations of the immune response. Increasing nociceptive signalling during inflammation strengthened subsequent immune recall.

The findings place sensory input within a brain–immune feedback loop, rather than treating it only as an alarm delivered to consciousness. They also raise a question about how pain relief interacts with the encoding of inflammatory states. That is not yet a clinical conclusion: the causal interventions and immune-recall findings were in mice, while the human evidence came from imaging.


These studies share a concern with what biological signals let us infer. A shifting neural map can retain useful information; a molecular seed can precede illness; an apparently meaningful EEG pattern can arise without a command. The mechanistic studies add another theme: brain function depends on supporting cells, sensory traffic and genes whose regulation responds to experience. Across these preprints, the strongest conclusions come from connecting signals to behaviour or testing mechanisms directly—and from keeping those connections distinct from what remains unproven.

Rising in this field

All the rising topics →

Was this letter useful to you?

Written by AI from the 411 papers of the week in this field. Most are preprints, not yet peer reviewed: the text says what their authors report.

Get one letter by email every week with a free account, all of them with Premium. Create a free account